Literature DB >> 1946401

Dietary protein restriction rapidly reduces transforming growth factor beta 1 expression in experimental glomerulonephritis.

S Okuda1, T Nakamura, T Yamamoto, E Ruoslahti, W A Border.   

Abstract

Dietary protein restriction has been shown to slow the rate of loss of kidney function in humans with progressive glomerulosclerosis due to glomerulonephritis or diabetes mellitus. A central feature of glomerulosclerosis is the pathological accumulation of extracellular matrix within the diseased glomeruli. Transforming growth factor beta 1 (TGF-beta 1) is known to have widespread regulatory effects on extracellular matrix and has been implicated as a major cause of increased extracellular matrix synthesis and buildup of pathological matrix within glomeruli in experimental glomerulonephritis. In the present study, it is shown that administration of a low protein diet to rats rapidly reduces the elevated expression of TGF-beta 1 mRNA and TGF-beta 1 protein that is known to occur within glomeruli after induction of glomerulonephritis. Compared to a normal protein diet, glomerulonephritic rats receiving the low protein diet did not develop an increase in glomerular extracellular matrix and showed significantly less proteinuria. Glomeruli isolated from glomerulonephritic rats fed the normal protein diet showed a marked increase in proteoglycan synthesis on day 7 of disease and were demonstrated to be secreting increased amounts of TGF-beta 1 into the medium, whereas glomeruli at the same point in time isolated from rats on a low protein diet showed no increase in proteoglycan production or TGF-beta 1 secretion. These results suggest that a mechanism of the rapid therapeutic effect of a low protein diet on experimental glomerulonephritis is through suppression of TGF-beta 1 expression and prevention of the induction of extracellular matrix synthesis within the injured glomeruli.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1946401      PMCID: PMC52801          DOI: 10.1073/pnas.88.21.9765

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Tumor-promoting activity of Epstein-Barr-virus-inducing factor transforming growth factor type beta (EIF/TGF-beta) is due to the induction of irreversible transformation.

Authors:  G Bauer; M Götschl; P Höfler
Journal:  Int J Cancer       Date:  1991-04-01       Impact factor: 7.396

2.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix.

Authors:  R A Ignotz; J Massagué
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

3.  Glomerulonephritis induced by monoclonal anti-Thy 1.1 antibodies. A sequential histological and ultrastructural study in the rat.

Authors:  W M Bagchus; P J Hoedemaeker; J Rozing; W W Bakker
Journal:  Lab Invest       Date:  1986-12       Impact factor: 5.662

4.  Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans.

Authors:  A Bassols; J Massagué
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

5.  Localized production of TGF-beta mRNA in tumour promoter-stimulated mouse epidermis.

Authors:  R J Akhurst; F Fee; A Balmain
Journal:  Nature       Date:  1988-01-28       Impact factor: 49.962

6.  Complement dependence of antibody-induced mesangial cell injury in the rat.

Authors:  T Yamamoto; C B Wilson
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

7.  Cell adhesion protein receptors as targets for transforming growth factor-beta action.

Authors:  R A Ignotz; J Massagué
Journal:  Cell       Date:  1987-10-23       Impact factor: 41.582

Review 8.  Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease.

Authors:  B M Brenner; T W Meyer; T H Hostetter
Journal:  N Engl J Med       Date:  1982-09-09       Impact factor: 91.245

9.  Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat.

Authors:  T Yamamoto; C B Wilson
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

10.  Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase.

Authors:  M Laiho; O Saksela; J Keski-Oja
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

View more
  13 in total

Review 1.  Transforming growth factor-beta in disease: the dark side of tissue repair.

Authors:  W A Border; E Ruoslahti
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 2.  Low-protein diet for diabetic nephropathy.

Authors:  Toshiki Otoda; Keizo Kanasaki; Daisuke Koya
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 3.  Renal scarring: a new look at an old problem.

Authors:  A M el Nahas
Journal:  Springer Semin Immunopathol       Date:  1994

4.  The suppressive effects of dietary protein restriction on the progression of renal impairment in OLETF rats.

Authors:  Miyoko Sakamoto; Yuko Akehi; Goro Mimura; Machiko Tanaka; Takeyuki Ohshita; Mayumi Yano; Yasuji Ishimaru; Junko Ono
Journal:  Clin Exp Nephrol       Date:  2006-12-20       Impact factor: 2.801

Review 5.  Transforming growth factor-beta: a clinical target for the treatment of diabetic nephropathy.

Authors:  Tracy A McGowan; Yanqing Zhu; Kumar Sharma
Journal:  Curr Diab Rep       Date:  2004-12       Impact factor: 4.810

6.  L-arginine may mediate the therapeutic effects of low protein diets.

Authors:  I Narita; W A Border; M Ketteler; E Ruoslahti; N A Noble
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

7.  Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

Authors:  S Kagami; W A Border; D E Miller; N A Noble
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 8.  Expression of cytokines and growth factors in human glomerulonephritides.

Authors:  R Waldherr; I L Noronha; Z Niemir; C Krüger; H Stein; G Stumm
Journal:  Pediatr Nephrol       Date:  1993-08       Impact factor: 3.714

9.  Effects of energy intake on type 1 plasminogen activator inhibitor levels in glomeruli of lupus-prone B/W mice.

Authors:  D A Troyer; B Chandrasekar; T Thinnes; A Stone; D J Loskutoff; G Fernandes
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

10.  Specific binding of endocrine transforming growth factor-beta 1 to vascular endothelium.

Authors:  K Dickson; A Philip; H Warshawsky; M O'Connor-McCourt; J J Bergeron
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.